Osteogen esis Imperfecta an d the Eye - Osteogenesis Imperfecta - page 274

[37] Scott A, Kashani S, Towler HMA. Progressive myopia due to

posterior staphyloma in type I osteogenesis imperfecta. Int
Ophthalmol 2005:167-9.

[50] Ehlers N, Hjortdal J. Corneal thickness: measurement and impli-

cations. Exp Eye Res 2004:543-8.

[51] Berggren L, Wessler E, Wennerström J. Intraocular pressure and

excretion of mucopolysaccharides in osteogenesis imperfecta.
Acta Ophthalmol 1969:122-8.

[38] Lanting PJ, Borsboom PC, te Meerman GJ, ten Kate LP.

Decreased scattering coeficient of blue sclerae. Clin Genet 1985:
187-90. [52] Khalil MK. Subhyaloid hemorrhage in osteogenesis imperfecta

tarda. Can J Ophthalmol 1983:251-2. [39] Sillence D, Butler B, Latham M, Barlow K. Natural history of

blue sclerae in osteogenesis imperfecta. Am J Med Genet 1993:
183-6.

[53] Ganesh A, Jenny C, Geyer J, Shouldice M, Levin AV. Retinal

hemorrhages in type I osteogenesis imperfecta after minor
trauma. Ophthalmology 2004:1428-31. [40] Kaiser-Kupfer MI, McCain L, Shapiro JR, Podgor MJ, Kupfer C,

Rowe D. Low ocular rigidity in patients with osteogenesis
imperfecta. Invest Ophthalmol Vis Sci 1981:807-9.

[54] Madigan WP, Wertz D, Cockerham GC, Thach AB. Retinal

detachment in osteogenesis imperfecta. J Pediatr Ophthalmol
Strabis 1994;31(4):268-9. [41] Kaiser-Kupfer MI, Podgor MJ, McCain L, Kupfer C, Shapiro JR.

Correlation of ocular rigidity and blue sclerae in osteogenesis
imperfecta. Trans Ophthalmol Soc UK 1985:191-5.

[55] Lepori JC, Raspiller A, Heymann V, George JL. Neovascular

choroid membrane and Lobstein's disease. Bull Soc Ophthalmol
Fr 1984:305-7. [42] Pirouzian A, O'Halloran H, Scher C, Jockin Y, Yaghmai R.

Traumatic and spontaneous scleral rupture and uveal prolapse in
osteogenesis imperfecta. J Pediatr Ophthalmol Strabis 2007:315-7.

[56] Rishi P, Rishi E, Venkatraman A. Intravitreal bevacizumab for

treatment of choroidal neovascularization associated with osteo-
genesis imperfecta. Indian J Ophthalmol 2012:229-31. [43] Viswanathan D, Goldberg I, Graham SL. Relationship of

change in central corneal thickness to visual ield progression
in eyes with glaucoma. Graefes Arch Clin Exp Ophthalmol
2013;251(6):1593-9.

[57] Benzimra JD, Kapoor B, Edmeades N, Burger A, Simcock PR.

Surgical repair of bilateral full thickness macular holes in a
patient with blue sclera secondary to osteogenesis imperfecta.
Eye 2012:1023-4. [44] Congdon NG, Broman AT, Bandeen-Roche K, Grover D,

Quigley HA. Central corneal thickness and corneal hysteresis
associated with glaucoma damage. Am J Ophthalmol 2006:868-75.

[58] Al Gazali LI, Sabrinathan K, Nair KG. A syndrome of osteogen-

esis imperfecta, optic atrophy, retinopathy and severe devel-
opmental delay in two sibs of consanguineous parents. Clin
Dysmorphol 1994;3(1):55-62.

[45] Smoli ´ska K, Olbromska W. Case of Ekman-Lobstein-van

der Hoeve syndrome with bilateral glaucoma and right-sided
thrombosis of the central retinal vein. Pol Tyg Lek 1977:843-4. [59] Arnould G, Dureux JB, Martin JY, Tridon P. Late oto-neurooph-

thalmological manifestations in a case of osteogenesis imper-
fecta congenita. Rev Otoneuroophthalmol 1957:405-13.

[46] Rosbach J, Vossmerbaeumer U, Renieri G, Pfeiffer N, Thieme H.

Osteogenesis imperfecta and glaucoma. A case report.
Ophthalmologe 2012:479-82. [60] Gogolkiewicz J. Optic nerve injury in a patient with osteogen-

esis imperfecta tarda. Klin Oczna 1974:269-72. [47] Aihara M, Lindsey JD, Weinreb RN. Ocular hypertension in mice

with a targeted type I collagen mutation. Invest Ophthalmol Vis
Sci 2003:1581-5.

[61] Cole DE, Carpenter TO. Bone fragility, craniosynostosis, ocu-

lar proptosis, hydrocephalus, and distinctive facial features:
a newly recognized type of osteogenesis imperfecta. J Pediatr
1987:76-80.

[48] Mabuchi F, Lindsey JD, Aihara M, Mackey MR, Weinreb RN.

Optic nerve damage in mice with a targeted type I collagen
mutation. Invest Ophthalmol Vis Sci 2004:1841-5. [62] Maumenee IH. Vitreoretinal degeneration as a sign of generalized

connective tissue diseases. Am J Ophthalmol 1979;88(3 Pt 1):432-49. [49] Dai YLJ, Duong-Polk X, Nguyen D, Hofer A, Weinreb RN.

Outlow facility in mice with a targeted type I collagen muta-
tion. Invest Ophthalmol Vis Sci 2009;50:5749-53.